Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) FCF Margin (2016 - 2026)

Healthequity has reported FCF Margin over the past 14 years, most recently at 35.73% for Q1 2026.

  • For Q1 2026, FCF Margin rose 1089.0% year-over-year to 35.73%; the TTM value through Jan 2026 reached 34.8%, up 648.0%, while the annual FY2026 figure was 34.8%, 648.0% up from the prior year.
  • FCF Margin for Q1 2026 was 35.73% at Healthequity, down from 42.77% in the prior quarter.
  • Over five years, FCF Margin peaked at 46.36% in Q3 2025 and troughed at 3.19% in Q2 2022.
  • A 5-year average of 23.97% and a median of 24.41% in 2022 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: plummeted -1873bps in 2023 and later surged 1499bps in 2024.
  • Year by year, FCF Margin stood at 20.97% in 2022, then increased by 10bps to 23.0% in 2023, then soared by 65bps to 37.99% in 2024, then increased by 13bps to 42.77% in 2025, then dropped by -16bps to 35.73% in 2026.
  • Business Quant data shows FCF Margin for HQY at 35.73% in Q1 2026, 42.77% in Q4 2025, and 46.36% in Q3 2025.